GO
Loading...

Enter multiple symbols separated by commas

Abiomed Inc

More

  • UPDATE 1-FDA approves Abiomed's blood pump device Monday, 23 Mar 2015 | 6:16 PM ET

    March 23- The U.S. Food and Drug Administration said it approved Abiomed Inc's miniature blood pump system that maintains heart function and circulation during high-risk procedures. Angioplasty and stenting are procedures used to re-open arteries in the heart that are blocked due to coronary artery disease, a condition that is the leading cause of death in...

  • FDA approves Abiomed's blood pump device Monday, 23 Mar 2015 | 5:51 PM ET

    March 23- The U.S. Food and Drug Administration said it approved Abiomed Inc's miniature blood pump system that maintains heart function and circulation during high-risk procedures. The device, Impella 2.5 System, can be used during angioplasty and stenting, the regulator said on Monday. Angioplasty and stenting are procedures used to re-open arteries in the...

  • Jan 27- Medical device maker Abiomed Inc raised its full-year revenue forecast and said the U.S. Food and Drug Administration had approved its heart pump, sending its stock nearly 32 percent in extended trading. Abiomed's heart pump, Impella RP, helps blood circulation for up to 14 days in patients who develop acute right heart failure following implantation,...

  • Jan 27- Medical device maker Abiomed Inc raised its full-year revenue forecast and said it had received U.S. approval for its heart pump, sending its stock soaring 24 percent after-hours. Abiomed raised its revenue estimate for the year ending March 31 to $223- $226 million from $209- $212 million. The company said the U.S. Food and Drug Administration had approved...

  • Midday movers: Telsa Motors, Microsoft & more Wednesday, 6 Nov 2013 | 12:54 PM ET

    Take a look at some of Wednesday's midday movers:

  • Midday Movers: AAPL, QCOM & More Wednesday, 17 Apr 2013 | 1:12 PM ET

    Take a look at some of Wednesday's midday movers:

  • After-Hours Buzz: MW, VRA, ETFC & More Wednesday, 13 Mar 2013 | 5:39 PM ET
    market-insider-stocks-to-watch-AB-200.jpg

    Check out which companies are making headlines after the bell Wednesday:

  • Lightning Round: MGM, Colfax & More Wednesday, 12 Dec 2012 | 5:57 PM ET
    Lightning Round: Markwest Energy, Bank of America & More

    It’s time for the Lightning Round. Cramer makes the call on viewer favorites.

  • --Abiomed Inc rescheduled second-quarter conference call to Nov. 1 at 8 am Eastern Time. --Accelrys Inc rescheduled third-quarter results to Oct. 31, after market. Its conference call will be held on Nov. 1, 9.30 am Eastern Time.

  • Cramer makes the call on viewer favorites.

  • Jim Cramer makes the call on viewers' favorite stocks.

  • Abiomed CEO on Blowout Earnings Tuesday, 7 Feb 2012 | 7:49 PM ET

    Michael Minogue discusses his company's earnings beat with Cramer.

  • Abiomed CEO on Blowout Earnings   Tuesday, 7 Feb 2012 | 6:45 PM ET
    Abiomed CEO on Blowout Earnings

    Medical device maker, Abiomed's CEO, Michael Minogue, discusses his company's earnings beat, and whether the ultra expensive stock, selling for 5.8 times next year's sales, still has room to run, with Mad Money's Jim Cramer.

  • You Ask, Cramer Answers Friday, 3 Jun 2011 | 6:58 PM ET

    It's time for some "Mad Mail!" Get Cramer's calls on Universal Display, Abiomed and more.

  • Greenberg: 10 Possible Takeover Targets Monday, 24 Jan 2011 | 3:55 PM ET

    A week ago, Michelle Leder at Footnoted, a Morningstar site, put out her Top 10 list based on the kinds of things she looks at in regulatory filings.

  • Lightning Round: Merck, Whole Foods, Lowe's and More Thursday, 15 May 2008 | 6:32 PM ET

    Cramer makes the call on viewers' favorite stocks.